Literature DB >> 17261504

Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation.

Nobuhiro Suzuki1, Naoki Hatakeyama, Masaki Yamamoto, Nobuo Mizue, Yuki Kuroiwa, Minami Yoda, Junko Takahashi, Yoshihiko Tani, Hiroyuki Tsutsumi.   

Abstract

Patients with chronic granulomatous disease (CGD) complicated by antimycotics-refractory invasive aspergillosis have an extremely poor prognosis if they cannot undergo allogeneic hematopoietic stem cell transplantation from a suitable related donor while in good clinical condition. We successfully treated a 20-year-old man with very rare McLeod phenotype CGD with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. We postulate that reduced-intensity conditioning-allogeneic hematopoietic stem cell transplantation is a promising therapeutic strategy for patients with CGD even if only unrelated-donor umbilical cord blood is available.

Entities:  

Mesh：

Year:  2007        PMID： 17261504     DOI： 10.1532/IJH9706129

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  5 in total

1.  Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.

Authors:  B Bielorai; A Toren; B Wolach; M Mandel; H Golan; Y Neumann; C Kaplinisky; M Weintraub; N Keller; N Amariglio; J Paswell; G Rechavi
Journal:  Bone Marrow Transplant       Date:  2000-11       Impact factor: 5.483

2.  Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.

Authors:  M E Horwitz; A J Barrett; M R Brown; C S Carter; R Childs; J I Gallin; S M Holland; G F Linton; J A Miller; S F Leitman; E J Read; H L Malech
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

3.  Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Jeffrey S Miller; John E Wagner
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

4.  Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease.

Authors:  A Bhattacharya; M Slatter; A Curtis; C E Chapman; D Barge; A Jackson; T J Flood; M Abinun; A J Cant; A R Gennery
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

Review 5.  Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

Authors:  Reinhard A Seger; Tayfun Gungor; Bernd H Belohradsky; Stephane Blanche; Pierre Bordigoni; Paolo Di Bartolomeo; Terence Flood; Paul Landais; Susanna Müller; Hulya Ozsahin; Justen H Passwell; Fulvio Porta; Shimon Slavin; Nico Wulffraat; Felix Zintl; Arnon Nagler; Andrew Cant; Alain Fischer
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113
  5 in total
  9 in total

Review 1.  Chronic granulomatous disease: lessons from a rare disorder.

Authors:  Brahm H Segal; Paul Veys; Harry Malech; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2011-01       Impact factor: 5.742

Review 2.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

3.  Advances in treatment for chronic granulomatous disease.

Authors:  Elizabeth M Kang; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Successful unrelated donor cord blood transplantation for chronic granulomatous disease.

Authors:  Tang-Her Jaing; Wen I Lee; Po-Jen Cheng; Shih-Hsiang Chen; Jing-Long Huang; Yung-Kuei Soong
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

5.  Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

Authors:  Priti Tewari; Paul L Martin; Adam Mendizabal; Suhag H Parikh; Kristin M Page; Timothy A Driscoll; Harry L Malech; Joanne Kurtzberg; Vinod K Prasad
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

6.  Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.

Authors:  M Hönig; W A Flegel; K Schwarz; J F Freihorst; U Baumann; A Seltsam; K-M Debatin; A S Schulz; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2009-06-08       Impact factor: 5.483

7.  Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient-a case report.

Authors:  Louise Helander; Chris McKinney; Kathleen Kelly; Samantha Mack; Mary Sanders; Janice Gurley; Larry J Dumont; Kyle Annen
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 8.  Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.

Authors:  James A Connelly; Rebecca Marsh; Suhag Parikh; Julie-An Talano
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

9.  Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.

Authors:  C Schuetz; M Hoenig; S Gatz; F Speth; U Benninghoff; A Schulz; K M Debatin; W Friedrich
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.